|
IL161717A0
(en)
|
2001-11-26 |
2004-09-27 |
Schering Corp |
Piperidine-based mch antagonists for treatment of obesity and cns disorders
|
|
CA2468015A1
(en)
|
2001-11-27 |
2003-06-05 |
Merck & Co., Inc. |
2-aminoquinoline compounds
|
|
DE10238865A1
(de)
*
|
2002-08-24 |
2004-03-11 |
Boehringer Ingelheim International Gmbh |
Neue Carbonsäureamid-Verbindungen mit MCH-antagonistischer Wirkung, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
US7351719B2
(en)
|
2002-10-31 |
2008-04-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
US20060194871A1
(en)
*
|
2003-04-11 |
2006-08-31 |
Barvian Kevin K |
Heterocyclic mchr1 antagoists
|
|
CN100418965C
(zh)
*
|
2003-08-15 |
2008-09-17 |
万有制药株式会社 |
咪唑并吡啶衍生物
|
|
KR100747042B1
(ko)
*
|
2003-08-19 |
2007-08-07 |
솔젠트 (주) |
신물질６-메틸-３-펜에틸-３,４-디히드로-１ｈ-큐나졸린-２-티온,이의 제조방법 및 이를 유효성분으로 포함하는 미백 효능조성물
|
|
US20070078125A1
(en)
*
|
2003-10-23 |
2007-04-05 |
Glaxo Group Limited |
Arylamine mch r1 antagonists
|
|
US7592373B2
(en)
|
2003-12-23 |
2009-09-22 |
Boehringer Ingelheim International Gmbh |
Amide compounds with MCH antagonistic activity and medicaments comprising these compounds
|
|
UA83416C2
(en)
|
2004-02-13 |
2008-07-10 |
Баниу Фармасьютикал Ко., Лтд. |
Fused ring 4-oxopyrimidine derivative
|
|
DE102004010893A1
(de)
*
|
2004-03-06 |
2005-09-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue ß-Ketoamid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
|
|
US7605176B2
(en)
|
2004-03-06 |
2009-10-20 |
Boehringer Ingelheim International Gmbh |
β-ketoamide compounds with MCH antagonistic activity
|
|
US20080125403A1
(en)
|
2004-04-02 |
2008-05-29 |
Merck & Co., Inc. |
Method of Treating Men with Metabolic and Anthropometric Disorders
|
|
DE102004017934A1
(de)
|
2004-04-14 |
2005-11-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
|
|
US7524862B2
(en)
|
2004-04-14 |
2009-04-28 |
Boehringer Ingelheim International Gmbh |
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
|
|
US7902356B2
(en)
|
2004-12-17 |
2011-03-08 |
Eli Lilly And Company |
Thiazolopyridinone derivates as MCH receptor antagonists
|
|
WO2006085692A1
(ja)
*
|
2005-02-14 |
2006-08-17 |
Banyu Pharmaceutical Co., Ltd |
４（３ｈ）－キナゾリノン誘導体の結晶
|
|
US7989445B2
(en)
|
2005-04-28 |
2011-08-02 |
Takeda Pharmaceutical Company Limited |
Thienopyrimidone compound
|
|
WO2007011286A1
(en)
*
|
2005-07-15 |
2007-01-25 |
Astrazeneca Ab |
Therapeutic agents
|
|
KR20080042158A
(ko)
*
|
2005-08-31 |
2008-05-14 |
셀진 코포레이션 |
이소인돌-이미드 화합물과 이를 포함하는 조성물 및 이를이용한 방법
|
|
KR101384132B1
(ko)
*
|
2005-10-19 |
2014-04-10 |
깃세이 야쿠힌 고교 가부시키가이샤 |
축합 복소환 유도체, 그것을 함유하는 의약 조성물 및 그의약 용도
|
|
US8618115B2
(en)
*
|
2005-10-26 |
2013-12-31 |
Bristol-Myers Squibb Company |
Substituted thieno[3,2-d]pyrimidinones as MCHR1 antagonists and methods for using them
|
|
US7745447B2
(en)
*
|
2005-10-26 |
2010-06-29 |
Bristol-Myers Squibb Company |
Substituted thieno[3,2-D]pyrimidines as non-basic melanin concentrating hormone receptor-1 antagonists
|
|
US8329704B2
(en)
|
2005-12-21 |
2012-12-11 |
Janssen Pharmaceutica, N.V. |
Substituted pyrazinone derivatives for use in MCH-1 mediated diseases
|
|
US7553836B2
(en)
|
2006-02-06 |
2009-06-30 |
Bristol-Myers Squibb Company |
Melanin concentrating hormone receptor-1 antagonists
|
|
EP1987020B1
(en)
*
|
2006-02-15 |
2012-10-03 |
Sanofi |
Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
|
|
WO2007093365A2
(en)
*
|
2006-02-15 |
2007-08-23 |
Sanofi-Aventis |
Novel amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
|
|
KR20080094699A
(ko)
|
2006-02-15 |
2008-10-23 |
사노피-아벤티스 |
신규 아미노알콜-치환된 아릴디하이드로이소퀴놀리논, 이의제조 방법 및 이의 약물로서의 용도
|
|
EP1986646A1
(en)
|
2006-02-15 |
2008-11-05 |
Sanofi-Aventis |
Novel azacycly-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
|
|
WO2007142217A1
(ja)
*
|
2006-06-07 |
2007-12-13 |
Banyu Pharmaceutical Co., Ltd. |
１－フェニルピリドン誘導体
|
|
MX2008015662A
(es)
|
2006-06-08 |
2009-01-12 |
Lilly Co Eli |
Nuevos receptores antagonistas de la hormona concentradora de melanina (mch).
|
|
JP5225269B2
(ja)
*
|
2006-06-08 |
2013-07-03 |
イーライ リリー アンド カンパニー |
新規なｍｃｈ受容体アンタゴニスト
|
|
JP2010500300A
(ja)
|
2006-08-08 |
2010-01-07 |
サノフィ−アベンティス |
アリールアミノアリール−アルキル−置換イミダゾリジン−２，４−ジオン、それらの製造法、それらの化合物を含有する薬剤、およびそれらの使用
|
|
WO2008020799A1
(en)
|
2006-08-18 |
2008-02-21 |
Astrazeneca Ab |
Thienopyrimidin-4-one and thienopyridazin-7-one derivatives as mch rl antagonists
|
|
EP2102208B1
(en)
|
2006-12-05 |
2014-04-23 |
Janssen Pharmaceutica NV |
Novel substituted diaza spiro pyridinone derivatives for use in mch-1 mediated diseases
|
|
CN101558075A
(zh)
|
2006-12-14 |
2009-10-14 |
伊莱利利公司 |
5-[4-(氮杂环丁烷-3-基氧基)-苯基]-2-苯基-5H-噻唑并[5,4-c]吡啶-4-酮衍生物及其作为MCH受体拮抗剂的用途
|
|
EP2121654A1
(en)
|
2007-01-10 |
2009-11-25 |
Albany Molecular Research, Inc. |
5-pyridinone substituted indazoles
|
|
JP2010525077A
(ja)
|
2007-04-25 |
2010-07-22 |
ブリストル−マイヤーズ スクイブ カンパニー |
非塩基性メラニン凝集ホルモン受容体−１アンタゴニスト
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
EP2527360B1
(en)
|
2007-06-04 |
2015-10-28 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
DE102007028925A1
(de)
|
2007-06-22 |
2008-12-24 |
Saltigo Gmbh |
Verfahren zur Herstellung von 2-Phenoxyacetalen und den daraus korrespondierenden 2-Phenoxycarbaldehyden
|
|
KR20100044225A
(ko)
|
2007-07-21 |
2010-04-29 |
알바니 몰레큘라 리써치, 인크. |
5-피리디논 치환된 인다졸
|
|
JP5632612B2
(ja)
*
|
2007-12-05 |
2014-11-26 |
あすか製薬株式会社 |
ラクタム化合物又はその塩及びｐｐａｒ活性化剤
|
|
PE20091928A1
(es)
|
2008-05-29 |
2009-12-31 |
Bristol Myers Squibb Co |
Tienopirimidinas hidroxisustituidas como antagonistas de receptor-1 de hormona concentradora de melanina no basicos
|
|
EP2810951B1
(en)
|
2008-06-04 |
2017-03-15 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
WO2010003624A2
(en)
|
2008-07-09 |
2010-01-14 |
Sanofi-Aventis |
Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
|
|
EP3241839B1
(en)
|
2008-07-16 |
2019-09-04 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
|
WO2010047982A1
(en)
|
2008-10-22 |
2010-04-29 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
JP5557845B2
(ja)
|
2008-10-31 |
2014-07-23 |
メルク・シャープ・アンド・ドーム・コーポレーション |
糖尿病用剤として有用な新規環状ベンゾイミダゾール誘導体
|
|
WO2010068601A1
(en)
|
2008-12-08 |
2010-06-17 |
Sanofi-Aventis |
A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
|
|
CA2689707A1
(en)
|
2009-11-16 |
2011-05-16 |
Jean-Simon Diallo |
Identification of the novel small molecule viral sensitizer vse1 using high-throughput screening
|
|
MX2012001729A
(es)
|
2009-08-26 |
2012-06-13 |
Sanofi Sa |
Nuevos hidratos cristalinos de fluoroglicosido heteroaromatico, productos farmaceuticos que comprenden estos compuestos, y su empleo.
|
|
US8895596B2
(en)
|
2010-02-25 |
2014-11-25 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
WO2012036233A1
(ja)
*
|
2010-09-17 |
2012-03-22 |
塩野義製薬株式会社 |
メラニン凝集ホルモン受容体アンタゴニスト活性を有する縮合へテロ環誘導体
|
|
BR112013021236B1
(pt)
|
2011-02-25 |
2021-05-25 |
Merck Sharp & Dohme Corp |
composto derivado de benzimidazol, e, composição
|
|
EP2683702B1
(de)
|
2011-03-08 |
2014-12-24 |
Sanofi |
Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
EP2683705B1
(de)
|
2011-03-08 |
2015-04-22 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2683698B1
(de)
|
2011-03-08 |
2017-10-04 |
Sanofi |
Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
EP2683699B1
(de)
|
2011-03-08 |
2015-06-24 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
US8828995B2
(en)
|
2011-03-08 |
2014-09-09 |
Sanofi |
Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
|
WO2012120052A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
US8871758B2
(en)
|
2011-03-08 |
2014-10-28 |
Sanofi |
Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
|
|
EP2683701B1
(de)
|
2011-03-08 |
2014-12-24 |
Sanofi |
Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
US8895547B2
(en)
|
2011-03-08 |
2014-11-25 |
Sanofi |
Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
|
|
KR101236188B1
(ko)
*
|
2011-03-10 |
2013-02-22 |
한국화학연구원 |
신규한 피롤로피리디논 유도체 및 그의 ｍｃｈ 수용체-1 관련 질환에 대한 치료학적 용도
|
|
HUP1100241A3
(en)
|
2011-05-06 |
2013-12-30 |
Richter Gedeon Nyrt |
Oxetane substituted pyrimidones
|
|
TW201837023A
(zh)
|
2011-07-01 |
2018-10-16 |
美商基利科學股份有限公司 |
作為離子通道調節劑之稠合雜環化合物
|
|
NO3175985T3
(https=)
|
2011-07-01 |
2018-04-28 |
|
|
|
US9527875B2
(en)
|
2012-08-02 |
2016-12-27 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
RU2015140066A
(ru)
|
2013-02-22 |
2017-03-30 |
Мерк Шарп И Доум Корп. |
Противодиабетические бициклические соединения
|
|
WO2014139388A1
(en)
|
2013-03-14 |
2014-09-18 |
Merck Sharp & Dohme Corp. |
Novel indole derivatives useful as anti-diabetic agents
|
|
CA2905438A1
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
|
CA2905435A1
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
|
SI3004138T1
(sl)
|
2013-06-05 |
2024-07-31 |
Bausch Health Ireland Limited |
Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo
|
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
BR112016028404A2
(pt)
*
|
2014-06-05 |
2018-07-03 |
Bayer Cropscience Aktiengesellschaft |
compostos bicíclicos como pesticidas
|
|
JP7114076B2
(ja)
|
2015-12-22 |
2022-08-08 |
シャイ・セラピューティクス・エルエルシー |
がん及び炎症性疾患の処置のための化合物
|
|
JP6998937B2
(ja)
*
|
2016-08-12 |
2022-01-18 |
バイエル・クロップサイエンス・アクチェンゲゼルシャフト |
２－（２－ジアゾニウム－６－置換フェニル）エタノール塩を環化させることによる４－置換２，３－ジヒドロ－１－ベンゾフラン誘導体の製造方法
|
|
EP3509588B1
(en)
*
|
2016-09-12 |
2023-06-07 |
Integral Health,Inc. |
Bicyclic compounds useful as gpr120 modulators
|
|
WO2018049324A1
(en)
|
2016-09-12 |
2018-03-15 |
Numerate, Inc. |
Monocyclic compounds useful as gpr120 modulators
|
|
US11072602B2
(en)
|
2016-12-06 |
2021-07-27 |
Merck Sharp & Dohme Corp. |
Antidiabetic heterocyclic compounds
|
|
WO2018118670A1
(en)
|
2016-12-20 |
2018-06-28 |
Merck Sharp & Dohme Corp. |
Antidiabetic spirochroman compounds
|
|
JP7514005B2
(ja)
|
2017-06-21 |
2024-07-10 |
シャイ・セラピューティクス・エルエルシー |
がん、炎症性疾患、ラソパシー、及び線維性疾患の治療のためのｒａｓスーパーファミリーと相互作用する化合物
|
|
TW201922724A
(zh)
|
2017-09-29 |
2019-06-16 |
德商拜耳廠股份有限公司 |
經取代之３－苯基喹唑啉－４（３ｈ）－酮及其用途
|
|
WO2019063708A1
(en)
|
2017-09-29 |
2019-04-04 |
Bayer Aktiengesellschaft |
SUBSTITUTED 3-PHENYLQUINAZOLIN-4 (3H) -ONES AND USES THEREOF
|
|
JP7407461B2
(ja)
|
2018-12-19 |
2024-01-04 |
シャイ・セラピューティクス・エルエルシー |
がん、炎症性疾患、ｒａｓ病、及び線維性疾患の処置のためのｒａｓスーパーファミリーと相互作用する化合物
|
|
CN110563730B
(zh)
*
|
2019-07-29 |
2022-03-25 |
江苏理工学院 |
高纯度n10-三氟乙酰蝶酸的制备方法
|
|
JP7834721B2
(ja)
|
2020-08-28 |
2026-03-24 |
アルビナス・オペレーションズ・インコーポレイテッド |
急速進行性線維肉腫タンパク質分解化合物及び関連する使用方法
|
|
CN113651800B
(zh)
*
|
2021-09-07 |
2022-08-19 |
山东铂源药业股份有限公司 |
一种甲磺酸奥希替尼的制备方法
|
|
EP4584258A1
(en)
|
2022-09-07 |
2025-07-16 |
Arvinas Operations, Inc. |
Rapidly accelerated fibrosarcoma (raf) degrading compounds and associated methods of use
|